Europe Brain Monitoring Market, By Product (Devices, Accessories), Product Type (Magnetoencephalograph, Electroencephalograph, Cerebral Oximeters, Functional Magnetic Resonance Imaging (fMRI), Intracranial Pressure Monitoring Devices, and Others) Disease Type (Traumatic Brain Injuries, Stroke, Dementia, Headache Disorders, Sleep Disorders, Epilepsy, Parkinson’s Disease, Huntington’s Disease, Other Diseases), End-Users (Hospitals, Neurology Centers, Clinics & Ambulatory Surgical Centers, Diagnostic Centers, Ambulances, Other End-Users) – Industry Trends and Forecast to 2030.
Europe Brain Monitoring Market Analysis and Size
Europe brain monitoring involves directly measuring the brain functioning, such as via electroencephalography (EEG), and those measuring aspects related to brain functions such as sleep patterns, gait, cognition, and gaze analysis
Data Bridge Market Research analyses that the Europe brain monitoring market which was USD 1,544.25 million in 2022, is expected USD 2,555.73 million by 2030, and is expected to undergo a CAGR of 6.5% during the forecast period. “Devices” dominates the product segment of the brain monitoring market attributable to rising non-invasive and sensitive devices development. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Europe Brain Monitoring Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Product (Devices, Accessories), Product Type (Magnetoencephalograph, Electroencephalograph, Cerebral Oximeters, Functional Magnetic Resonance Imaging (fMRI), Intracranial Pressure Monitoring Devices, and Others) Disease Type (Traumatic Brain Injuries, Stroke, Dementia, Headache Disorders, Sleep Disorders, Epilepsy, Parkinson’s Disease, Huntington’s Disease, Other Diseases), End-Users (Hospitals, Neurology Centers, Clinics & Ambulatory Surgical Centers, Diagnostic Centers, Ambulances, Other End-Users)
|
|
Countries Covered
|
Germany, U.K., France, Spain, Italy, Russia, Turkey, Belgium, Nether lands, Switzerland, Rest of Europe
|
|
Market Players Covered
|
GE HealthCare (U.S.), Siemens Healthcare GmbH (Germany), Medtronic (Ireland), Compumedics Limited (Australia), NIHON KOHDEN CORPORATION (Japan) , Natus Medical Incorporated (U.S.), Boston Scientific Corporation (U.S.), Integra LifeSciences (U.S.), Masimo (U.S.), Elekta (Sweden) and Neural Analytics, Inc. (U.S.), Spiegelberg GmbH & Co. KG (Germany), Koninklijke Philips N.V. (Netherlands), Cerenion Oy (Finland), Edwards Lifesciences Corporation (U.S.), B. Braun SE (Germany), Healthcare 21 Ltd (U.K.), Advanced Brain Monitoring, Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Brain monitoring techniques aim to gather information about the electrical, hemodynamic, metabolic, or structural aspects of the brain to aid in diagnosis, treatment, research, and understanding of various neurological conditions and disorders. Brain monitoring technologies encompass a wide range of non-invasive or minimally invasive methods, including electroencephalography (EEG), magnetoencephalography (MEG), functional magnetic resonance imaging (fMRI), near-infrared spectroscopy (NIRS), positron emission tomography (PET), and others. These techniques allow healthcare professionals and researchers to measure and analyze brain waves, neural connectivity, blood flow, oxygenation levels, and other relevant parameters
Europe Brain Monitoring Market Dynamics
Drivers
- Rising Prevalence of Neurological Disorders
In Europe, there is a rising prevalence of neurological disorders such as epilepsy, alzheimer’s disease, Parkinson’s disease, stroke etc. The requirement of continuous monitoring of these patients is one of the key driver for market growth
- Advancements in Brain Monitoring Technologies
The precision, clarity, and utility of devices have all been improved by the quick advances in brain monitoring technology. More advanced and dependable monitoring systems have been created as a result of advancements in EEG, MEG, fMRI, NIRS, and other approaches. These innovations draw researchers and healthcare professionals, fostering commercial expansion
Opportunity
- Growing Geriatric Population
Age-related neurological diseases are more common in Europe due to the continent's large elderly population. By assisting in the early identification and monitoring of cognitive decline, brain monitoring technology can support healthcare practitioners in developing individualised treatment programmes and prompt treatments
Restraint/Challenge
High costs associated with devices and continuous monitoring is a huge concern that is expected the restrain the market growth. Along with this, poor re-imbursement scenario add upon to the economic burden on the patient. These factors may restain the market growth in the forecast period
This Europe brain monitoring market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Europe brain monitoring market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth
Recent Developments
- In March 2019, Masimo (U.S.) received CE Mark approval for its next-generation SedLine brain function monitor for pediatric patients aged between one and 18 years of age; this product assesses the brain function while the patient is under anesthesia
- In March 2018, Nihon kohden (Japan) launched aireeg WEE-1200, a wireless EEG system that provides real-time data during long-term epilepsy monitoring, intensive care, and routine EEG.
Europe Brain Monitoring Market Scope
The Europe brain monitoring market is segmented on the basis of product, product type, disease type, and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications
Products
- Devices
- Accessories
Product Type
- Magnetoencephalograph
- Electroencephalograph
- Cerebral Oximeters
- Functional Magnetic Resonance Imaging (fMRI)
- Intracranial Pressure Monitoring Devices
- Others
Disease Type
- Traumatic Brain Injuries
- Stroke
- Dementia
- Headache Disorders
- Sleep Disorders
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Diseases
End-Users
- Hospitals, Neurology Centers
- Clinics & Ambulatory Surgical Centers
- Diagnostic Centers
- Ambulances
- Others
Brain Monitoring Market Regional Analysis/Insights
The Europe brain monitoring market is analysed and market size insights and trends are provided by product, product type, disease type, and end users as referenced above
The countries covered in the Europe brain monitoring market report is Germany, U.K., France, Spain, Italy, Russia, Turkey, Belgium, Nether lands, Switzerland, Rest of Europe
Germany is expected to dominate the market due to presence of major market players in the region and well established healthcare facilities
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The Europe brain monitoring market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Europe brain monitoring market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Europe brain monitoring market. The data is available for historic period from 2010 to 2020.
Competitive Landscape and Brain monitoring Market Share Analysis
The Europe brain monitoring market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company’s focus related to Europe brain monitoring market
Some of the major players operating in the Europe brain monitoring market are:
- GE HealthCare. (U.S.)
- Siemens Healthcare GmbH (Germany)
- Medtronic (Ireland)
- Compumedics Limited (Australia)
- NIHON KOHDEN CORPORATION (Japan)
- Natus Medical Incorporated (U.S.)
- Boston Scientific Corporation (U.S.)
- Integra LifeSciences (U.S.)
- Masimo (U.S.)
- Elekta (Sweden)
- Neural Analytics, Inc. (U.S.)
- Spiegelberg GmbH & Co. KG (Germany)
- Koninklijke Philips N.V. (Netherlands)
- Cerenion Oy (Finland)
- Edwards Lifesciences Corporation (U.S.)
- B. Braun SE (Germany)
- Healthcare 21 Ltd (U.K.)
- Advanced Brain Monitoring, Inc. (U.S.)
SKU-